about
Proapoptotic activity of bortezomib in gastrointestinal stromal tumor cells.Mutations in BRCA2 and taxane resistance in prostate cancerA novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification - implications for chemoprevention.PDGFRA activating mutations in gastrointestinal stromal tumors.The DREAM complex mediates GIST cell quiescence and is a novel therapeutic target to enhance imatinib-induced apoptosis.Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneityThe DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors.HPV-16 E7 reveals a link between DNA replication stress, fanconi anemia D2 protein, and alternative lengthening of telomere-associated promyelocytic leukemia bodies.Imatinib mesylate induces quiescence in gastrointestinal stromal tumor cells through the CDH1-SKP2-p27Kip1 signaling axis.KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway.Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate.Cullin 1 functions as a centrosomal suppressor of centriole multiplication by regulating polo-like kinase 4 protein levels.Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs).KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs).Genomic features of renal cell carcinoma with venous tumor thrombus.Targeting ETV1 in gastrointestinal stromal tumors: tripping the circuit breaker in GIST?Correlation between genomic index lesions and mpMRI and Ga-PSMA-PET/CT imaging features in primary prostate cancerClosing in on accurate risk prediction and disease management for patients with operable GISTFamilial Gastrointestinal Stromal Tumor Syndrome: Phenotypic and Molecular Features in a KindredEvaluating the volume ratio of bone marrow affected by fibrosis: A parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemiaDifferential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells
P50
Q33584749-4CA394E6-269D-40D6-A7CA-A5FBBA442440Q33870601-32933A8D-38CD-4EEC-9254-74562B3C8B2FQ33968462-CCCDDD21-9285-4A42-B2B6-DBDD81587886Q34169772-5B51FA43-84E1-4CDC-B3CC-1E8F03D0BB87Q34352283-675ADC19-24EB-41FD-BDE3-9EEEFF14A62BQ37010342-FEF7889D-D1D6-411E-8CD2-9E68A8025DD1Q38212772-B3D4162C-D1B2-446E-951F-638BB33178E1Q39910328-BCBA96A5-6B9D-42BF-885B-D7B487DF36ACQ39923070-588C7E42-82D9-42A8-AF67-FE63132E9291Q40124442-3D5EFBAB-2B00-482E-A72A-F15F7D1543B6Q42315791-4CC7CBD4-E4DF-4E15-88F7-60B226D4AD3FQ43068860-2388E507-53DD-4B42-9C2C-EFA3FEF1B491Q44790860-80F7B4A8-8278-4210-8EE7-6DCEA9DAB5D0Q44956779-A3B04A65-D1B0-44F2-818A-980FDAFF28CCQ45003972-B2E9DCF6-1125-454A-A6FF-58141AA1A239Q55024664-601248CE-A1C7-48FC-B418-D30220CB7FD0Q55066110-1C7E30C4-08A4-479F-9557-F509D89E30D1Q59335329-B3E00C54-CF5D-4DCC-A397-1A8DA99603B4Q60984248-31D672AE-3794-4047-B4DA-F287AB98B4C3Q60984331-5BECA1EA-D5B6-4133-8B4A-32999AE83BE6Q60984352-CDCE47B2-2B6F-4896-B08D-FD70D9061DF7Q90546356-7A8B94F4-2741-4940-BC71-24AE8F8388EA
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anette Duensing
@ast
Anette Duensing
@en
Anette Duensing
@es
Anette Duensing
@nl
Anette Duensing
@sl
type
label
Anette Duensing
@ast
Anette Duensing
@en
Anette Duensing
@es
Anette Duensing
@nl
Anette Duensing
@sl
altLabel
Anette Nasarek
@en
Anette U. Duensing
@en
Anette Ute Duensing
@en
prefLabel
Anette Duensing
@ast
Anette Duensing
@en
Anette Duensing
@es
Anette Duensing
@nl
Anette Duensing
@sl
P106
P1153
6602654070
6602890196
P21
P31
P496
0000-0002-0168-4067